RT Journal Article
SR Electronic
T1 Updating the OMERACT Filter: Implications of Filter 2.0 to Select Outcome Instruments Through Assessment of “Truth”: Content, Face, and Construct Validity
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1000
OP 1004
DO 10.3899/jrheum.131310
VO 41
IS 5
A1 Peter Tugwell
A1 Maarten Boers
A1 Maria-Antonietta D’Agostino
A1 Dorcas Beaton
A1 Annelies Boonen
A1 Clifton O. Bingham III
A1 Ernest Choy
A1 Philip G. Conaghan
A1 Maxime Dougados
A1 Catia Duarte
A1 Daniel E. Furst
A1 Francis Guillemin
A1 Laure Gossec
A1 Turid Heiberg
A1 Désirée M. van der Heijde
A1 Sarah Hewlett
A1 John R. Kirwan
A1 Tore K. Kvien
A1 Robert B. Landewé
A1 Philip J. Mease
A1 Mikkel Østergaard
A1 Lee Simon
A1 Jasvinder A. Singh
A1 Vibeke Strand
A1 George Wells
YR 2014
UL http://www.jrheum.org/content/41/5/1000.abstract
AB Objective. The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The “Truth” section of the OMERACT Filter requires that criteria be met to demonstrate that the outcome instrument meets the criteria for content, face, and construct validity. Methods. Discussion groups critically reviewed a variety of ways in which case studies of current OMERACT Working Groups complied with the Truth component of the Filter and what issues remained to be resolved. Results. The case studies showed that there is broad agreement on criteria for meeting the Truth criteria through demonstration of content, face, and construct validity; however, several issues were identified that the Filter Working Group will need to address. Conclusion. These issues will require resolution to reach consensus on how Truth will be assessed for the proposed Filter 2.0 framework, for instruments to be endorsed by OMERACT.